Baker Bros. Advisors LP Kymera Therapeutics, Inc. Transaction History
Baker Bros. Advisors LP
- $9.02 Billion
- Q4 2024
A detailed history of Baker Bros. Advisors LP transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Baker Bros. Advisors LP holds 5,995,929 shares of KYMR stock, worth $178 Million. This represents 2.67% of its overall portfolio holdings.
Number of Shares
5,995,929
Previous 5,995,929
-0.0%
Holding current value
$178 Million
Previous $284 Million
15.0%
% of portfolio
2.67%
Previous 3.04%
Shares
7 transactions
Others Institutions Holding KYMR
# of Institutions
187Shares Held
60.3MCall Options Held
49.6KPut Options Held
17K-
Price T Rowe Associates Inc Baltimore, MD6.87MShares$203 Million0.03% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$153 Million7.77% of portfolio
-
Avoro Capital Advisors LLC New York, NY5.15MShares$153 Million3.02% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$145 Million32.49% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.89MShares$145 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $1.62B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...